Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
132.20B
Market cap132.20B
Price-Earnings ratio
14.03
Price-Earnings ratio14.03
Dividend yield
3.94%
Dividend yield3.94%
Average volume
14.64M
Average volume14.64M
High today
$65.02
High today$65.02
Low today
$63.26
Low today$63.26
Open price
$63.87
Open price$63.87
Volume
4.47M
Volume4.47M
52 Week high
$68.10
52 Week high$68.10
52 Week low
$42.52
52 Week low$42.52

Stock Snapshot

Bristol-Myers Squibb(BMY) stock is priced at $64.72, giving the company a market capitalization of 132.2B. It carries a P/E multiple of 14.03 and pays a dividend yield of 3.94%.

During the trading session on 2026-08-13, Bristol-Myers Squibb(BMY) shares reached a daily high of $65.02 and a low of $63.26. At a current price of $64.72, the stock is +2.3% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 4.47M, compared to an average daily volume of 14.64M.

The stock's 52-week range extends from a low of $42.52 to a high of $68.10.

The stock's 52-week range extends from a low of $42.52 to a high of $68.10.

BMY News

TipRanks 1h
Bristol-Myers Squibb Expands Kidney Pipeline With New Golcadomide Renal Study

Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter,...

Simply Wall St 1d
Why Bristol Myers Squibb Is Back In The Spotlight - simplywall.st

...

Why Bristol Myers Squibb Is Back In The Spotlight - simplywall.st
Nasdaq 2d
November 20th Options Now Available For Bristol Myers Squibb

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options become available today, for the November 20th expiration. One of the key inputs that goes in...

November 20th Options Now Available For Bristol Myers Squibb

Analyst ratings

61%

of 31 ratings
Buy
35.5%
Hold
61.3%
Sell
3.2%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.